Patents Assigned to VACSYN Inc.
  • Patent number: RE35706
    Abstract: The invention relates to muramyleptide derivatives resulting essentially from the conjugation or the coupling, as the case may require, through an arm, between a muramylpeptide and a group containing two atoms contiguous with one another to each of which is attached a lipophile chain comprising from 8 to 100 carbon atoms, preferably from 14 to 24 carbon atoms. The derivatives according to the invention are endowed with remarkable stimulating properties with respect to the activation of macrophages, of which they amplify the tumoricidal properties.
    Type: Grant
    Filed: October 25, 1994
    Date of Patent: December 30, 1997
    Assignee: VACSYN Inc.
    Inventors: Nigel Phillips, Fran.cedilla.oise Audibert, Jean-Marie Bernard, Louis Chedid, Pierre Lefrancier, Michel Level, Monique Parant